Sr. Manager, Financial Systems & Master Data

Reporting to the Assoc. Director of US Accounting, this individual will be responsible for leading the successful design and delivery of key financial systems & master data governance solutions for Legend Biotech. This position will closely align with all IT business partners, TechOps and Quality representatives and will drive data quality, integrity and data management across the organization. The Senior Manager of Financial Systems & Master Data will maintain the Chart of Accounts in SAP & OneStream as well as enable business users to leverage and use the data as a differentiator in running the business., * Manage Legend's portfolio of ERP data-related initiatives across all finance data objects within SAP & OneStream

• Build and drive plans to improve data practices for operational, reporting and analysis needs - Inclusive of development of processes, control and best business practices around financial data management
• Partner with IT and drive successful implementations of incremental SAP modules (WBS, Treasury module)
• Work with IT to manage the upgrades and enhancements of core financial systems
• Lead and develop implementation of finance data management core principles, in collaboration with other SAP workstreams (e.g. P2P / D2D / EWM / etc.) data leads, and in alignment with the IT Data Management teams
• Collaborate in the development of Master Data Governance activities, inclusive of maintenance of workflows process in accordance with the Company's Delegation of Authority policy
• Build organization understanding of data lifecycles from creation to end use, working with subject matter experts in various business functions, operations and IT teams
• Resolve any Banking / COGS / Budget / BOM costing issues quickly and effectively
• Assist with the development and implementation of internal and external financial reporting, data track changes, development of standard operating procedures and work instructions
• Collaborate with Cybersecurity Team for protecting Legend's data, data leakage and incident response investigations
• Maintain the Company's Chart of Accounts in all financial systems and maintain clearly defined mapping between ERP and Consolidation platforms.
• Partner with FP&A to be the gate keeper for the Company's cost centers
• Ensure timely and accurate allocation of project spend across the business units
• Maintain access to authorized data users amongst the various systems
• Understand data lineage and data mapping for financial data
• Collaborate with S4 Hana GRC team to review data logs for appropriateness
• Assist with internal and external auditors requirements for SOX compliance on IT/Segregation of Duties related controls., Applicants must be authorized to work in the United States. As part of our commitment to maintaining a lawful workforce and ensuring compliance with federal employment regulations, we participate in the E-Verify program. If you are selected for employment, you will be required to complete the Form I-9 process, and your employment eligibility will be verified through E-Verify in accordance with applicable federal law. We are committed to providing a fair, transparent, and welcoming hiring experience for all candidates.

• Bachelor's degree.
• Concentration in IT a plus.
• A minimum of 6+ years of experience with data management solutions: Migration, Business Objects, Data Quality, etc.
• Ability to work independently and successfully, prioritize and manage multiple tasks simultaneously, integrate cross-functional issues and balance competing priorities effectively. Must be able to manage shifting priorities to meet critical deadlines in a fast paced and dynamic, growing environment.
• SAP knowledge is preferrable
• Ability to promote a mindset of continuous improvement, problem solving, and prevention.
• Hands on experience leading data definitions and process development, data quality modeling, and solving efforts of data implementation projects collaborating with cross functional teams (internally and externally)
• Experience working closely with data and ERP integrators to ensure changes are appropriately adopted and synchronized with the overall Legend Biotech ERP and data strategy
• Prior experience with SAP query viewer / design, and advanced GUI access
• Prior experience deploying P2P, D2D, RTR/FI modules from design to deployment
• Proficient with processing large volume of data, designing queries and advanced analytics reporting tools.
• Proficient in Project Management.

#Li-LB1

The base pay range below is what Legend Biotech USA Inc. reasonably expects to offer at the time of posting. Actual compensation may vary based on experience, skills, qualifications, and geographic location. The company reserves the right to modify this range as needed and in accordance with applicable laws.

Other Types of Pay: Performance-based bonus and/or equity is available to employees in eligible roles.

Benefits and Paid Time Off: Medical, dental, and vision insurance as well as a 401(k) retirement plan with a company match that vests fully on day one. We offer eight (8) weeks of paid parental leave after just three (3) months of employment, and a paid time off policy that includes vacation time, personal time, sick time, floating holidays, and eleven (11) company holidays. Additional voluntary benefits include flexible spending and health savings accounts, life and AD&D insurance, short- and long-term disability coverage, legal assistance, and supplemental plans such as pet, critical illness, accident, and hospital indemnity insurance. We also provide voluntary commuter benefits, family planning and care resources, well-being initiatives, and peer-to-peer recognition programs; demonstrating our ongoing commitment to building a culture where our people feel empowered, supported, and inspired to do their best work.

Pay Range (Base Pay):

$127,313 - $167,099 USD

Please note: These benefits are offered exclusively to permanent full-time employees. Contractors are not eligible for benefits through Legend Biotech.

Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide. Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma., Legend Biotech was founded as an early-stage cell therapy company in 2014. The company was the brainchild of visionary scientists who recognized that antibody-based therapeutics could potentially treat disease and possessed the backgrounds in immunology and gene editing to take the leap. For two years, Legend Biotech, then known as the "Legend Project," operated in a room the size of a freight elevator, with the goal of creating a cell therapy for multiple myeloma, a hematological cancer that often relapses and can become refractory. The team produced nanobodies for single-domain antibody drugs and ultimately extended the half-life of the nanobodies with proprietary technologies. In 2015, Legend's scientists focused on research for chimeric antigen-receptor T-cells (CAR-T) targeting the BCMA protein, making the biotech one of the first companies in the world to engineer CAR-T cells for the BCMA protein. In 2016, investigator-initiated trials began in China. In 2017, data from the trials were presented at the American Society for Clinical Oncology (ASCO), which led to a partnership with biopharmaceutical company Janssen Biotech, Inc. to co-develop the anti-BCMA CAR-T, ciltacabtagene autoleucel (cilta-cel). Applications seeking approval of cilta-cel for the treatment of patients with RRMM are currently under regulatory review by several health authorities around the world. CARVYKTI (ciltacabtagene autoleucel) was approved by the U.S. Food and Drug Administration in February 2022 and received conditional marketing approval from the European Medicines Agency in May 2022. Today Legend Biotech is a global, commercial-stage company driven by a passion for patients. We continue to build our pipeline of cell therapy platforms, which includes CAR-T, CAR-NK, CAR-γδ T and non-gene-editing CAR technologies. Our goal is to bring hope and opportunity to patients and their families by continuing to explore unique technologies.